Growth Metrics

Burning Rock Biotech (BNR) Free Cash Flow (2020 - 2025)

Historic Free Cash Flow for Burning Rock Biotech (BNR) over the last 6 years, with Q3 2025 value amounting to $2.3 million.

  • Burning Rock Biotech's Free Cash Flow rose 11451.81% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.8 million, marking a year-over-year increase of 7337.5%. This contributed to the annual value of -$13.4 million for FY2024, which is 6399.49% up from last year.
  • Burning Rock Biotech's Free Cash Flow amounted to $2.3 million in Q3 2025, which was up 11451.81% from -$9.5 million recorded in Q2 2025.
  • In the past 5 years, Burning Rock Biotech's Free Cash Flow registered a high of $2.6 million during Q4 2024, and its lowest value of -$66.2 million during Q4 2022.
  • For the 5-year period, Burning Rock Biotech's Free Cash Flow averaged around -$14.2 million, with its median value being -$15.9 million (2024).
  • As far as peak fluctuations go, Burning Rock Biotech's Free Cash Flow tumbled by 31304.9% in 2021, and later surged by 21573.58% in 2024.
  • Burning Rock Biotech's Free Cash Flow (Quarter) stood at -$17.6 million in 2021, then tumbled by 275.71% to -$66.2 million in 2022, then soared by 96.59% to -$2.3 million in 2023, then skyrocketed by 215.74% to $2.6 million in 2024, then fell by 11.8% to $2.3 million in 2025.
  • Its Free Cash Flow was $2.3 million in Q3 2025, compared to -$9.5 million in Q2 2025 and -$3.2 million in Q1 2025.